Clinical Trial Update: A Single-cell Approach to Identify Biomarkers of Efficacy and Toxicity for ICI in NSCLC

View source ↗

Summary

This clinical trial investigates single-cell biomarkers to predict efficacy and toxicity of immune checkpoint inhibitors in non-small cell lung cancer. Recruitm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Interstitial Lung Disease
• Non-small Cell Lung Cancer

Drugs mentioned

• Immune checkpoint inhibitors (immune checkpoint inhibitor)

Snippet

Sponsor: Universitaire Ziekenhuizen KU Leuven | Conditions: Lung Diseases, Interstitial, NSCLC | Status: RECRUITING